GGrantIndex
Sort

50,496 grants matching lung cancer

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma

$724,798
Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Metabolic Studies of Mouse Models of Obesity and Diabetes

$724,700
Oksana Gavrilova · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2016 · DK

Cincinnati Center for Excellence in Molecular Hematology

$724,661
Yi Zheng · Cincinnati Childrens Hosp Med Ctr · P30 · FY2012 · DK

MAb-based targeted chemotherapy of lung cancer

$724,653
Serengulam V Govindan · Immunomedics, Inc. · R44 · FY2008 · CA

Nicotine Dependence to Smoking Cessation: Sequencing Common and Rare Variants

$724,557
Laura Jean Bierut · Washington University · R01 · FY2017 · DA

Inflammation Pathways and COPD in the Development of Lung Cancer

$724,405
Ann G Schwartz · Wayne State University · R01 · FY2013 · CA

Integrated analyses of genetics, epigenetics, and gene expression

$724,403
Maxwell Lee · Division Of Basic Sciences - Nci · ZIH · FY2019 · CA

Supplemental Se and Vitamin E and Pulmonary Function

$724,307
Cornell University Ithaca · R01 · FY2003 · HL

Appraisal and Diagnostic Delay in Colon Cancer

$724,234
Laura A Siminoff · Virginia Commonwealth University · R01 · FY2008 · CA

Tools for drug efficacy studies in perfused tissue models

$724,224
Jelena Vukasinovic · Lena Biosciences, Inc. · R44 · FY2018 · TR

Device for Promoting Survival of Congested Tissue Flaps

$724,039
John A. Russell · Spectrocon, Llc · R44 · FY2009 · HL

Development of a platform for spatial functional genomics

$723,980
Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AT

Development of a platform for spatial functional genomics

$723,980
Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AT

Assessing the integration of tobacco cessation treatment into lung cancer screening

$723,961
Elyse R Park · Massachusetts General Hospital · R01 · FY2018 · CA

Integrating Biomarkers into Lung Cancer Risk Profiling

$723,835
Mattias Alexander Johansson · University Of New Mexico Health Scis Ctr · U19 · FY2024 · CA

Clinical Diagnostic Studies and Treatment of Patients with Immune Deficiencies

$723,661
Suk De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Enabling Ultra Low Dose PET/CT Imaging

$723,657
Paul E Kinahan · University Of Washington · R01 · FY2012 · CA

FFPE Validation of a Survival Gene Signature in HPV-Negative Oral Cavity Cancer

$723,600
Chu Chen · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA

124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer

$723,362
Steven M Larson · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

Cancer Genomics Technology Development

$723,259
Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Quantitative and Spatially-Resolved Analysis of the Tumor Immune Contexture for Optimal Diagnosis and Treatment of Lung Cancer

$722,919
Kurt A Schalper · Yale University · R37 · FY2025 · CA

Novel Pathogen Associated Cancers (PQ12)

$722,856
Denise A. Galloway · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA

Mechanisms of protective memory CD8 T-cell induction by mRNA-LNP vaccines

$722,737
Luis J. Sigal · Thomas Jefferson University · R01 · FY2023 · AI

Endothelial Cell-Targeted Amatoxin Conjugates for Effective Therapy of Breast Cancer

$722,712
Bogdan Olenyuk · Proteogenomics Research Instit/Sys/ Med · R01 · FY2021 · CA

Clinical Diagnostic Studies and Treatment of Patients with Immune Deficiencies

$722,652
Suk De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI